Mereo Stock Volume Indicators Chaikin AD Line

MREO
 Stock
  

USD 0.83  0.01  1.19%   

Mereo BioPharma volume indicators tool provides the execution environment for running the Chaikin AD Line indicator and other technical functions against Mereo BioPharma. Mereo BioPharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the Chaikin AD Line indicator function is designed to identify and follow existing trends. Mereo BioPharma volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The Accumulation/Distribution line was developed by Marc Chaikin. It is interpreted by looking at a divergence in the direction of the indicator relative to Mereo BioPharma price. If the Accumulation/Distribution Line is trending upward it indicates that the price may follow. If the Accumulation/Distribution Line becomes flat while Mereo BioPharma Group price is still rising (or falling) then it signals a flattening of the price values.
.

Mereo BioPharma Technical Analysis Modules

Most technical analysis of Mereo BioPharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mereo from various momentum indicators to cycle indicators. When you analyze Mereo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Mereo BioPharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mereo BioPharma Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mereo BioPharma Group based on widely used predictive technical indicators. In general, we focus on analyzing Mereo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mereo BioPharma's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Mereo BioPharma's intrinsic value. In addition to deriving basic predictive indicators for Mereo BioPharma, we also check how macroeconomic factors affect Mereo BioPharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Mereo BioPharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Mereo BioPharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.040.834.67
Details
Intrinsic
Valuation
LowReal ValueHigh
0.142.856.69
Details
Naive
Forecast
LowNext ValueHigh
0.0184420.924.76
Details
1 Analysts
Consensus
LowTarget PriceHigh
8.009.0010.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mereo BioPharma. Your research has to be compared to or analyzed against Mereo BioPharma's peers to derive any actionable benefits. When done correctly, Mereo BioPharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Mereo BioPharma Group.

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum
Sold few shares
Disruptive Technologies
Sold few shares
Macroaxis Index
Invested over 400 shares
Dividend Beast
Invested over 70 shares
Chemicals Makers
Invested over 40 shares
Baby Boomer Prospects
Invested over 60 shares
Blockchain
Invested over 30 shares
Macroaxis Picks
Invested less than 1 share
Additionally, see Correlation Analysis. Note that the Mereo BioPharma Group information on this page should be used as a complementary analysis to other Mereo BioPharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Mereo Stock analysis

When running Mereo BioPharma Group price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Mereo BioPharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo BioPharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
104.6 M
Return On Assets
(0.21) 
Return On Equity
(0.25) 
The market value of Mereo BioPharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo BioPharma's market value can be influenced by many factors that don't directly affect Mereo BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Mereo BioPharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.